169 related articles for article (PubMed ID: 28396094)
1. YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma.
Kojima Y; Hayakawa F; Morishita T; Sugimoto K; Minamikawa Y; Iwase M; Yamamoto H; Hirano D; Imoto N; Shimada K; Okada S; Kiyoi H
Pharmacol Res; 2017 Jun; 120():242-251. PubMed ID: 28396094
[TBL] [Abstract][Full Text] [Related]
2. YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines.
Sachita K; Yu HJ; Yun JW; Lee JS; Cho SD
J Oral Pathol Med; 2015 Nov; 44(10):785-91. PubMed ID: 25475012
[TBL] [Abstract][Full Text] [Related]
3. Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.
Wagner V; Hose D; Seckinger A; Weiz L; Meißner T; Rème T; Breitkreutz I; Podar K; Ho AD; Goldschmidt H; Krämer A; Klein B; Raab MS
Oncotarget; 2014 Nov; 5(21):10237-50. PubMed ID: 25296978
[TBL] [Abstract][Full Text] [Related]
4. YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-κB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells.
Woo SM; Min KJ; Seo BR; Kwon TK
Oncotarget; 2016 Sep; 7(38):61520-61532. PubMed ID: 27528031
[TBL] [Abstract][Full Text] [Related]
5. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells.
Chiou JT; Lee YC; Huang CH; Shi YJ; Wang LJ; Chang LS
Toxicol Appl Pharmacol; 2020 Jan; 387():114857. PubMed ID: 31837377
[TBL] [Abstract][Full Text] [Related]
6. YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells.
Feng W; Yoshida A; Ueda T
Biochem Biophys Res Commun; 2013 May; 435(1):52-7. PubMed ID: 23618862
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
8. YM155 suppresses cell proliferation and induces cell death in human adult T-cell leukemia/lymphoma cells.
Sasaki R; Ito S; Asahi M; Ishida Y
Leuk Res; 2015 Dec; 39(12):1473-9. PubMed ID: 26547260
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells.
Hussain AR; Ahmed M; Ahmed SO; Al-Thari S; Khan AS; Razack S; Platanias LC; Al-Kuraya KS; Uddin S
Leuk Lymphoma; 2009 Jul; 50(7):1204-13. PubMed ID: 19557642
[TBL] [Abstract][Full Text] [Related]
10. Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263.
Tang H; Shao H; Yu C; Hou J
Biochem Pharmacol; 2011 Nov; 82(9):1066-72. PubMed ID: 21784061
[TBL] [Abstract][Full Text] [Related]
11. YM155 enhances ABT-737-mediated apoptosis through Mcl-1 downregulation in Mcl-1-overexpressed cancer cells.
Woo SM; Min KJ; Seo BR; Seo YH; Jeong YJ; Kwon TK
Mol Cell Biochem; 2017 May; 429(1-2):91-102. PubMed ID: 28120212
[TBL] [Abstract][Full Text] [Related]
12. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
Zhang W; Liu Y; Li YF; Yue Y; Yang X; Peng L
Cell Physiol Biochem; 2016; 38(6):2426-37. PubMed ID: 27287458
[TBL] [Abstract][Full Text] [Related]
13. YM155 induces EGFR suppression in pancreatic cancer cells.
Na YS; Yang SJ; Kim SM; Jung KA; Moon JH; Shin JS; Yoon DH; Hong YS; Ryu MH; Lee JL; Lee JS; Kim TW
PLoS One; 2012; 7(6):e38625. PubMed ID: 22723871
[TBL] [Abstract][Full Text] [Related]
14. AML sensitivity to YM155 is modulated through AKT and Mcl-1.
de Necochea-Campion R; Diaz Osterman CJ; Hsu HW; Fan J; Mirshahidi S; Wall NR; Chen CS
Cancer Lett; 2015 Sep; 366(1):44-51. PubMed ID: 26118775
[TBL] [Abstract][Full Text] [Related]
15. Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cells.
Tange N; Hayakawa F; Yasuda T; Odaira K; Yamamoto H; Hirano D; Sakai T; Terakura S; Tsuzuki S; Kiyoi H
Biomed Pharmacother; 2020 Aug; 128():110330. PubMed ID: 32504922
[TBL] [Abstract][Full Text] [Related]
16. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M
Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777
[TBL] [Abstract][Full Text] [Related]
17. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway.
Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S
Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878
[TBL] [Abstract][Full Text] [Related]
18. Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo.
Ishikawa C; Tanaka J; Katano H; Senba M; Mori N
Mar Drugs; 2013 Sep; 11(9):3410-24. PubMed ID: 24018901
[TBL] [Abstract][Full Text] [Related]
19. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.
Nakahara T; Kita A; Yamanaka K; Mori M; Amino N; Takeuchi M; Tominaga F; Hatakeyama S; Kinoyama I; Matsuhisa A; Kudoh M; Sasamata M
Cancer Res; 2007 Sep; 67(17):8014-21. PubMed ID: 17804712
[TBL] [Abstract][Full Text] [Related]
20. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
